Skip to main content
TipRanks
Go Ultimate75% OFF

Opko Health (XCY) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Opko Health has a market cap or net worth of CHF 1.05B. The enterprise value is CHF 1.33B.

Market Cap
CHF 1.05B
Enterprise Value
CHF 1.33B

Share Statistics

Opko Health has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
―
Owned by Insiders
37.41%
Owned by Institutions
22.24%

Financial Efficiency

Opko Health’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -11.32%.

Return on Equity (ROE)
-0.18
Return on Assets (ROA)
-0.12
Return on Invested Capital (ROIC)
-11.32%
Return on Capital Employed (ROCE)
-0.12
Revenue Per Employee
266.76K
Profits Per Employee
-99.20K
Employee Count
2,275
Asset Turnover
0.31
Inventory Turnover
7.27

Valuation Ratios

The current PE Ratio of Opko Health is -8.70. Opko Health’s PEG ratio is 0.09.

PE Ratio
-8.70
PS Ratio
2.49
PB Ratio
1.12
Price to FCF
-9.22
Price to Operating Cash Flow
-10.03
PEG Ratio
0.09

Income Statement

In the last 12 months, Opko Health had revenue of 606.88M and earned -225.68M in profits. Earnings per share was -0.30.

Revenue
606.88M
Gross Profit
128.05M
Operating Income
-218.99M
Pretax Income
-241.39M
Net Income
-225.68M
EBITDA
-41.30M
Earnings Per Share (EPS)
-0.30

Cash Flow

In the last 12 months, operating cash flow was -125.05M and capital expenditures -10.29M, giving a free cash flow of -135.34M billion.

Operating Cash Flow
-125.05M
Free Cash Flow
-135.34M
Free Cash Flow per Share
-0.18

Dividends & Yields

Opko Health pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-10.85%
Earnings Yield
-11.81%

Important Dates

Opko Health upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 04, 2026
Next Earnings Date
Mar 04, 2027
Ex-Dividend Date
―

Financial Position

Opko Health as a current ratio of 3.97, with Debt / Equity ratio of 34.20%

Current Ratio
3.97
Quick Ratio
3.52
Debt to Market Cap
0.42
Net Debt to EBITDA
-1.56
Interest Coverage Ratio
-2.02

Taxes

In the past 12 months, Opko Health has paid -15.71M in taxes.

Income Tax
-15.71M
Effective Tax Rate
0.07

Enterprise Valuation

Opko Health EV to EBITDA ratio is -50.22, with an EV/FCF ratio of -10.13.

EV to Sales
2.73
EV to EBITDA
-50.22
EV to Free Cash Flow
-10.13
EV to Operating Cash Flow
-10.97

Balance Sheet

Opko Health has CHF 390.22M in cash and marketable securities with CHF 514.09M in debt, giving a net cash position of -CHF 123.86M billion.

Cash & Marketable Securities
CHF 390.22M
Total Debt
CHF 514.09M
Net Cash
-CHF 123.86M
Net Cash Per Share
―
Tangible Book Value Per Share
CHF 0.28

Margins

Gross margin is 38.64%, with operating margin of -25.46%, and net profit margin of -29.51%.

Gross Margin
38.64%
Operating Margin
-25.46%
Pretax Margin
-31.72%
Net Profit Margin
-29.51%
EBITDA Margin
-5.44%
EBIT Margin
-23.33%

Analyst Forecast

The average price target for Opko Health is CHF 2.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
CHF 2.57
Price Target Upside
―
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
―
EPS Growth Forecast
―

Scores

Smart Score
6
AI Score
―